DP Diagnostic Products

Diagnostic Products Corporation (NYSE:DP) today announced that they have recently won an M2M Magazine Value Chain Award for their innovative Internet based service and support product, DPC RealTime Solutions. M2M, the leading publication covering machine-to-machine communications, celebrated the winners of the 2005 Value Chain Awards June 28, 2005 at the M2M United conference in Chicago. From hundreds of nominees, a panel of highly recognized industry analysts judged the entries and awarded DPC the gold award in the Manufacturing category. The Value Chain Awards honor the most successful adopters of M2M technology and their enablers, the teams of solution providers that made their successes possible. The awards highlight the process of effectively combining multiple technologies, such as device-connectivity hardware, radio modules, network service and provision, as well as application software and infrastructure. DPC is the world's leading independent manufacturer of immunodiagnostic systems and reagents. In 1998, DPC pioneered the realm of remote immunoassay instrument monitoring when it introduced Remote Diagnostics, a modem based support feature that now has become an industry standard. Continuing in this tradition of innovation leadership, DPC is the first company to offer worldwide availability of an Internet based service support product for its immunoassay systems. State-of-the-art RealTime Solutions (RTS) including DPC RealTime Service, allows DPC to monitor the IMMULITE 2000 and IMMULITE 2500 systems' functions 24 hours a day without operator intervention, ultimately shifting the service focus from reactive (meaning repair) to proactive or prevention, and further enhancing the system's operational efficiency. DPC RealTime Solutions, developed in collaboration with Questra Corporation's Intelligent Device Management (IDM) software application, was successfully launched in 2003 both domestically and internationally. The customer response has been overwhelmingly positive as a result of better operational efficiency and improved productivity for clinical laboratories using these services. The newest applications, OnLine Reports, now allows customers, from any Internet enabled computer, the ability to view a Levey-Jennings report, a peer group report, an adjustment report and an on-line target range report for DPC's quality control material. These applications will provide the clinical lab manager unprecedented access to information on the assay performance on the DPC IMMULITE systems. "We are honored to have DPC RealTime Solutions recognized by M2M Magazine," stated Douglas Olson, DPC's Chief Scientific Officer and President of DPC Instruments Systems Division. "Our mission at DPC is to continuously strive to be the best diagnostic company in the world, by providing the highest quality products, service and support to our customers. RealTime Solutions provides our customers with a proactive approach to service support while expanding the product's functionality with OnLine Reports - a new application that allows our customers to view Levey-Jennings Reports, peer group reports and additional informative reports from any Internet enabled computer. It's great to have the results of our efforts affirmed by the industry." "We congratulate DPC on winning this prestigious award," said Walt Rossi, Vice President of Marketing at Questra. "Their RealTime Solutions is an excellent example of how medical device manufacturers and their customers can benefit from remote intelligent device management." About Diagnostic Products Corporation Diagnostic Products Corporation, founded in 1971, is the global leader dedicated exclusively to immunodiagnostics. DPC's product menu includes over 75 immunoassays and more than 360 specific allergens and allergy panels. In addition, DPC addresses the chemistry and laboratory automation testing needs of its customers through partnerships with manufacturers of chemistry systems and reagents. The combined chemistry and immunoassay menu is one of the largest and most diversified available, covering most laboratory tests requested. DPC also designs and manufactures automated laboratory instrumentation, which provides fast, accurate results while reducing labor and reagent costs. DPC sells its products to hospitals, clinics and laboratories in more than 100 countries. *Additional Company information can be found on DPC's website at www.dpcweb.com. Except for the historical information contained herein, this press release contains forward-looking statements that involve risks and uncertainties that could cause actual results to differ materially. These factors include the effects of governmental or other actions relating to the FDA's decision that its Application Integrity Policy should be applied to the Company or relating to the Company's Chinese affiliate; the rate of customer demand for the Company's products; the Company's ability to successfully market new and existing products; its dependence on certain suppliers; domestic and foreign government regulation; its ability to keep abreast of technological innovations and to translate them into new products; competition; political and economic instability in certain markets including the movements of foreign currencies relative to the dollar; and other risks and uncertainties disclosed from time to time in the Company's SEC reports and filings. About Questra Corporation Questra is an enterprise software company leading the development and marketing of intelligent device management solutions. Equipment manufacturers use the Questra Smart Service Solution, which proactively monitors and manages remote intelligent devices, to provide superior yet cost-effective support to their customers. Agfa, General Electric, Heidelberg, Kodak, Samsung, Scientific Applications International Corporation (SAIC), and Waters, among other Fortune 1000 companies, have chosen Questra software as part of their corporate strategies to advance from reactive to proactive equipment service and support. For more information, visit www.questra.com.